InsiderLens

15 Jan 2026PURCHASESurrozen, Inc./DE5,59019.89 USD

indirect· By The Column Group III, LP

15 Jan 2026PURCHASESurrozen, Inc./DE6,30319.89 USD

indirect· By The Column Group III-A, LP

20 Jan 2026PURCHASESurrozen, Inc./DE9,56819.60 USD

indirect· By The Column Group III-A, LP

16 Jan 2026PURCHASESurrozen, Inc./DE1,35820.00 USD

indirect· By The Column Group III-A, LP

20 Jan 2026PURCHASESurrozen, Inc./DE8,48419.60 USD

indirect· By The Column Group III, LP

16 Jan 2026PURCHASESurrozen, Inc./DE1,20420.00 USD

indirect· By The Column Group III, LP

14 Jan 2026PURCHASESurrozen, Inc./DE2,92719.99 USD

indirect· By The Column Group III-A, LP

14 Jan 2026PURCHASESurrozen, Inc./DE2,59619.99 USD

indirect· By The Column Group III, LP

13 Jan 2026PURCHASESurrozen, Inc./DE5,86119.80 USD

indirect· By The Column Group III, LP

13 Jan 2026PURCHASESurrozen, Inc./DE6,60919.80 USD

indirect· By The Column Group III-A, LP

06 Jan 2026PURCHASESurrozen, Inc./DE8,00319.89 USD

indirect· By The Column Group III-A, LP

06 Jan 2026PURCHASESurrozen, Inc./DE7,09719.89 USD

indirect· By The Column Group III, LP

05 Dec 2025PURCHASESurrozen, Inc./DE16,38119.54 USD

indirect· By The Column Group III-A, LP

04 Dec 2025PURCHASESurrozen, Inc./DE2,79117.35 USD

indirect· By The Column Group III-A, LP

04 Dec 2025PURCHASESurrozen, Inc./DE2,47517.35 USD

indirect· By The Column Group III, LP

05 Dec 2025PURCHASESurrozen, Inc./DE14,50319.54 USD

indirect· By The Column Group III, LP

13 Nov 2025PURCHASESurrozen, Inc./DE167,30712.65 USD

indirect· By The Column Group III-A, LPfirst after silence

13 Nov 2025PURCHASESurrozen, Inc./DE148,15012.65 USD

indirect· By The Column Group III, LP

26 Mar 2025GRANT_AWARDSurrozen, Inc./DE2,6660.00 USD

directderiv

05 Jun 2024GRANT_AWARDSurrozen, Inc./DE1,3330.00 USD

directderiv

04 Apr 2024PURCHASESurrozen, Inc./DE90,89715.50 USD

indirect· By The Column Group III, LP

04 Apr 2024PURCHASESurrozen, Inc./DE102,65115.50 USD

indirect· By The Column Group III-A, LP

05 Apr 2024OTHERNGM BIOPHARMACEUTICALS INC949,862—

indirect· See footnotes

05 Apr 2024OTHERNGM BIOPHARMACEUTICALS INC2,650,177—

indirect· See footnote

05 Apr 2024OTHERNGM BIOPHARMACEUTICALS INC90,442—

indirect· See footnote

Kutzkey Tim.

Kutzkey Tim.